"","Blank 1","Frequency","Blank 2","Frequency","Blank 3","Frequency"
"1","",11,"receiving",10,"who have not been on a stable or decreasing dose of corticosteroid for at least 7 days prior to enrollment are not eligible                                               ",3
"4","corticosteroids",2,"who are receiving dexamethasone or other",1,"who have not been on a stable or decreasing dose of corticosteroid for at least 7 days prior to enrollment are not eligible if used to modify immune adverse events related to prior therapy > = 14 days must have elapsed since last dose of corticosteroid                        ",3
"6","solid tumor",1,"must be off",1,"must have been on a stable or decreasing dose of corticosteroid for at least 7 days prior to enrollment if used to modify immune adverse events related to prior therapy > = 14 days must have elapsed since last dose of corticosteroid                           ",2
"2","",NA,"requiring daily systemic",1,"are not eligible patients must have been off corticosteroids for 7 days prior to start of chemotherapy                                                     ",1
"3","",NA,"requiring",1,"are eligible for this trial                                                                 ",1
"5","",NA,"",NA,"must be on a stable or decreasing dose for at least 1 week prior to enrollment it is recommended that patients be off all steroid therapy or receive the least dose that will control their neurologic symptoms                           ",1
"7","",NA,"",NA,"prior to registration if gbm patient is receiving corticosteroids patient must be on a stable or decreasing dose of corticosteroids for at least 5 days prior to baseline mri mri or computed tomography ct if steroids are added or the steroids dose is increased between the date of the screening mri or ct and the start of treatment a new baseline mri or ct is required",1
"8","",NA,"",NA,"are not eligible patients must not have received systemic corticosteroids within 7 days prior to enrollment if used to modify immune adverse events related to prior therapy > = 14 days must have elapsed since last dose of corticosteroid note use of topical or inhaled corticosteroids will not render a patient ineligible                ",1
"9","",NA,"",NA,"who have not been on a stable or decreasing dose of corticosteroid for the 7 days prior to enrollment are not eligible if used to modify immune adverse events related to prior therapy > = 14 days must have elapsed since last dose of corticosteroid                         ",1
